Abbott Laboratories (Germany) Today
| ABL Stock | 122.70 0.34 0.28% |
Performance16 of 100
| Odds Of DistressLess than 9
|
Abbott Laboratories is selling for under 122.70 as of the 31st of January 2025; that is 0.28 percent down since the beginning of the trading day. The stock's last reported lowest price was 121.92. Abbott Laboratories has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 2nd of November 2024 and ending today, the 31st of January 2025. Click here to learn more.
Moving together with Abbott Stock
Moving against Abbott Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Abbott Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Abbott Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Abbott Laboratories (ABL) is traded on XETRA Stock Exchange in Germany and employs 115,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 165.42 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abbott Laboratories operates under Healthcare sector and is part of Medical Devices industry. The entity has 1.74 B outstanding shares.
Abbott Laboratories generates positive cash flow from operations, but has no cash available
Check Abbott Laboratories Probability Of Bankruptcy
Ownership AllocationAbbott Laboratories holds a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Abbott Ownership Details
Abbott Laboratories Risk Profiles
Although Abbott Laboratories' alpha and beta are two of the key measurements used to evaluate Abbott Laboratories' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.843 | |||
| Semi Deviation | 0.5058 | |||
| Standard Deviation | 1.06 | |||
| Variance | 1.13 |
Abbott Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Abbott Laboratories Corporate Management
Elected by the shareholders, the Abbott Laboratories' board of directors comprises two types of representatives: Abbott Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abbott. The board's role is to monitor Abbott Laboratories' management team and ensure that shareholders' interests are well served. Abbott Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abbott Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Leinenweber | Licensing Relations | Profile | |
| Robert Ford | Pres Chairman | Profile | |
| James Young | VP Officer | Profile | |
| Elaine Leavenworth | VP Officer | Profile | |
| Mary Moreland | Ex HR | Profile | |
| Robert Funck | Exec CFO | Profile | |
| Daniel Salvadori | Ex Products | Profile |
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.